VCEL:NASDAQ
베리셀
US$44.20
arrow_downward
-0.76%(-0.34) 1D
8월 14일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoVCEL의 주요 통계 생성 중...
시가
US$44.53
고가
US$44.55
저가
US$43.65
시가총액
22.63억
평균 거래량
49.09만
거래량
1.00
주가수익률
105.82
52주 최고가
US$49.32
52주 최저가
US$28.95
EPS
US$0.42
베타
1.07
유통 주식수
5120.70만
직원 수
398
시가
US$44.53
고가
US$44.55
저가
US$43.65
시가총액
22.63억
평균 거래량
49.09만
거래량
1.00
주가수익률
105.82
52주 최고가
US$49.32
52주 최저가
US$28.95
EPS
US$0.42
베타
1.07
유통 주식수
5120.70만
직원 수
398
뉴스 기사
웹 소스 기반
프로필
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before.
In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts. Wikipedia
베리셀에 관한 정보